substance p has been researched along with Hepatoblastoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jia, MM; Li, XJ; Li, YS; Mao, XQ; Tang, HB; Yang, YL | 1 |
| Berger, M; de Agustín Asencio, JC; Garnier, A; Ilmer, M; Kappler, R; Muñoz, M; Neth, O; Salinas-Martín, MV; von Schweinitz, D | 1 |
2 other study(ies) available for substance p and Hepatoblastoma
| Article | Year |
|---|---|
Involvement of substance p/neurokinin-1 receptor in the analgesic and anticancer activities of minimally toxic fraction from the traditional Chinese medicine Liu-Shen-Wan in vitro.
Topics: Analgesics; Antineoplastic Agents; Apoptosis; Bradykinin; Complex Mixtures; Dose-Response Relationship, Drug; Down-Regulation; Ganglia, Spinal; Hep G2 Cells; Hepatoblastoma; Humans; Liver Neoplasms; Medicine, Chinese Traditional; Mitochondria; Neoplasms; Pain; Phytotherapy; Receptors, Neurokinin-1; Substance P | 2014 |
Hepatoblastoma cells express truncated neurokinin-1 receptor and can be growth inhibited by aprepitant in vitro and in vivo.
Topics: Animals; Apoptosis; Aprepitant; Cell Line, Tumor; Cell Proliferation; Child; Cytostatic Agents; Drug Synergism; Female; Gene Expression; Hep G2 Cells; Hepatoblastoma; Humans; Liver Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Morpholines; Neovascularization, Pathologic; Neurokinin-1 Receptor Antagonists; Protein Isoforms; Receptors, Neurokinin-1; Substance P; Xenograft Model Antitumor Assays | 2014 |